Angelos M. Stergiou
President and CEO, Director · SELLAS Life Sciences Group, Inc.
Individual
- 2024
- Jun 18, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Angelos M. Stergiou files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Katherine Bach Kalin - $101K in SLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Angelos M. Stergiou?
Angelos M. Stergiou is a corporate insider, tracked as President and CEO, Director of SELLAS Life Sciences Group, Inc. (SLS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Angelos M. Stergiou last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 3 filings going back to 2024.
